April 14 (Reuters) - EUROBIO SCIENTIFIC SA ALERS.PA :
* FY REVENUE EUR 59.1 MILLION VERSUS EUR 50.5 MILLION YEAR
AGO
* FY EBITDA EUR 7.0 MILLION VERSUS EUR 5.0 MILLION YEAR AGO
* FY NET PROFIT EUR 3.2 MILLION VERSUS LOSS OF EUR 2.8
MILLION
YEAR AGO
* HAS SO FAR RECORDED TOTAL ORDER AMOUNT OF AROUND EUR 14
MILLION
FOR ALL TESTS AND EQUIPMENT RELATED TO COVID-19
* COMPANY ANTICIPATES SLOWDOWN IN ITS ACTIVITY WITH
REDUCTION IN
TURNOVER TO LEVELS SIMILAR TO THOSE USUALLY OBSERVED DURING
HOLIDAY PERIODS
* TOTAL NET CASH OF EUR 7.6 MILLION AT 31, DEC. 2019
* TO DATE, INCREASED ACTIVITY LINKED TO COVID-19 HAS MORE
THAN
COMPENSATED FOR THIS SLOWDOWN: COMPANY NOW EXPECTS SIGNIFICANT
INCREASE IN ITS TURNOVER IN FY 2020
Source text for Eikon: ID:nNDL1KNLt6
Further company coverage: ALERS.PA
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))